Kewaunee Scientific (KEQU) vs YD Bio (YDES)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Kewaunee Scientific (KEQU) has outperformed YD Bio (YDES) over the past year, losing 22.8% versus a loss of 66.1%. YD Bio is the larger company by market cap ($410.1 million vs $97.9 million), about 4.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | KEQU | YDES |
|---|---|---|
| Share price | $33.82 | $5.79 |
| Market cap | $97.92M | $410.11M |
| 1-day change | -0.06% | -1.53% |
| YTD return | -9.60% | -52.50% |
| 1-year return | -22.84% | -66.06% |
| 5-year return | +156.21% | — |
| P/E ratio (TTM) | 12.25 | — |
| Forward P/E | 15.66 | — |
| EPS (TTM) | $2.76 | $-0.04 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $46.57 | $22.00 |
| 52-week low | $32.00 | $1.70 |
| Distance from 52-week high | -27.38% | -73.68% |
| Average volume | 4.22K | 284.92K |
| Shares outstanding | 2.90M | 70.83M |
| Employees | 1,231 | 13 |
| Sector | Consumer Cyclical | Health Care |
| Industry | Furnishings, Fixtures & Appliances | Medical Specialities |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- YD Bio is about 4.2 times larger than Kewaunee Scientific by market value ($410.11M vs $97.92M).
- KEQU has outperformed YDES by 43.2 percentage points over the past year.
- The two companies sit in different sectors: Kewaunee Scientific in Consumer Cyclical and YD Bio in Health Care.
About Kewaunee Scientific
KEQU stock →Kewaunee Scientific Corporation, together with its subsidiaries, designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products in the United States and internationally. It operates through two segments, Lab Products Group (LPG) and International.
Consumer Cyclical · Furnishings, Fixtures & Appliances · 1,231 employees
About YD Bio
YDES stock →YD Bio Limited, a biopharmaceutical company, focuses on regulated diagnostics, life science clinical services, and healthcare product commercialization in the United States and Taiwan. The company offers eye disease treatment products, 3D LensMate Artificial Tears, a natural tear-mimicking lubricant that moisturizes the eyes and relieves dry eye symptoms; 3D LensMate Eye Drops, an ophthalmic solution to alleviate symptoms of dry eye syndrome, including irritation, foreign body sensation, and eye fatigue; and LSC Eye Drug/Injection, an injectable ophthalmic drug is being developed for the treatment of various retinal and macular disorders, such as age-related macular degeneration, macular edema, choroidal and subretinal neovascularization, and neovascular glaucoma.
Health Care · Medical Specialities · 13 employees
KEQU vs YDES FAQ
Which is bigger, Kewaunee Scientific or YD Bio?
YD Bio (YDES) is larger, with a market capitalization of $410.11M compared with $97.92M for Kewaunee Scientific (KEQU).
Which stock has performed better over the past year, KEQU or YDES?
KEQU returned -22.84% over the past 12 months, compared with -66.06% for YDES (price return, excluding dividends). Past performance does not predict future results.
Are Kewaunee Scientific and YD Bio in the same industry?
No. Kewaunee Scientific is in the Consumer Cyclical sector, while YD Bio is in Health Care.